In line with this, previous studies also demonstrated that SCFAs, especially acetate, contributed to obesity and liver steatosis as they provide approximately 10% of daily caloric consumption and might enhance nutrient absorption by promoting the expression of glucagon-like peptide 2, obesity, and liver steatosis that could trigger liver inflammation and NAFLD [35]. The gene discussed is GCG; the disease is fatty liver disease.